Genomic Translation

ACCE: A Short Course: Public Health Assessment of Genetic Tests for Screening and Prevention

September 27-28, 2004
Hyatt Regency Hotel ~ Atlanta, Ga

 

Meeting Summary

View Meeting Agenda

---


Presented by Office of Genomics and Disease Prevention (OGDP), Centers for Disease Control and Prevention, Atlanta, GA and Foundation for Blood Research (FBR), Scarborough, ME

 

This short course was intended to inform participants about systematic approaches for evidence-based assessment of genetic tests.  The content was developed to be useful to public health and health care professionals, policy makers, and others who are involved in the development, evaluation, utilization, regulation, and reimbursement of genetic tests for screening and prevention.  Speakers addressed issues related to pre- and post-market evaluation of genetic tests, and included case studies and lessons learned from the CDC-sponsored ACCE Project and other review processes.The more than 60 professionals from the United States, Canada, the United Kingdom and the Netherlands who attended the short course were from state and Federal public health agencies, health care practice, health care provider organizations, industry, voluntary health organizations and advocacy groups, academic centers, and health technology assessment centers.

 

Centers for Disease Control & Prevention

Muin Khoury, MD, PhD
Director, OGDP, CDC

Linda A. Bradley, PhD
Geneticist, OGDP, CDC

Melanie F. Myers, PhD
Public Health Geneticist, OGDP, CDC

Paula W. Yoon, ScD, MPH
Epidemiologist, OGDP, CDC

D. Joe Boone, PhD
Associate Director for Science,
Public Health Practice Program Office, CDC

Peter A. Briss, MD, MPH
Chief, Community Guide Branch, CDC

Scott Grosse, PhD
Health Economist, National Center for Birth Defects and Developmental Disabilities, CDC

 

Foundation for Blood Research

James E. Haddow, MD
Medical Director, FBR

Glenn E. Palomaki, BS
Director, Biometry/Epidemiology, FBR

Monica McClain, PhD
Asst. Director, Biometry/Epidemiology, FBR